| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| None | ||||||
| SCOOP Ratings From Last week: | ||||||
| None | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Phenomix (PHMX) |
Morgan Stanley
Citi
|
$86.25 | 1-Star | |||
| Xanodyne Pharmaceuticals (XANO) |
Morgan Stanley
Deutsche Bank
|
$86.25 | 1-Star | |||
| New Terms | ||||||
| Eyeblaster (EYEB) | Deutsche Bank | $115.00 | 2-Stars | |||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Oct. 20, 2008 | Manager(s) | Offered | Raised | Price | 10/24/08 | Change |
| None |
